NCT02788825View on ClinicalTrials.gov

STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies

NACompletedINTERVENTIONAL
Enrollment

687

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Prostate Cancer
Interventions
PROCEDURE

Targeted biopsies using Magnetic Resonance Imaging guiding

Prostate biopsies targeted by findings on MRI where findings are classified according to PI-RADS v2.

Trial Locations (2)

17177

Karolinska Universitetssjukhuset, Solna, Stockholm

Unknown

Aleris Oslo, Oslo

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02788825 - STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies | Biotech Hunter | Biotech Hunter